Articles From: Shell International Finance B.V. and Royal Dutch Shell plc to Shire, AstraZeneca fall in London after U.S. tax move


2014/8/29
LONDON , August 29, 2014 /PRNewswire/ -- Voting Rights and Capital In conformity with the Disclosure and Transparency Rules, we hereby notify the market of the following: Royal Dutch Shell plc's (NYSE: RDS.A) (NYSE: RDS.B) capital consists of 3,942,743,022 A shares and 2,440,410,614 B shares, each with equal voting rights.
Sign-up for Shell International Finance B.V. and Royal Dutch Shell plc investment picks
By Justin Scheck LONDON --
Sign-up for Shell profit jumps on higher prices, liquid petroleum output investment picks
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- A deluge of earnings reports is keeping investors in Europe busy on Thursday, with oil companies one of the few sectors in black after encouraging earnings reports from Royal Dutch Shell PLC and BG Group PLC.
Sign-up for Shell, BG among major European movers; Adidas slides investment picks
From IncentiveWorks in Toronto, Starwood Hotels & Resorts Worldwide Inc., (NYSE:HOT) today announced that it will embark on a $90 million renovation of the Sheraton Centre Toronto, resulting in a floor-to-ceiling transformation of the hotel's 1,371 guest rooms and suites.
Sign-up for Sheraton Centre Toronto Announces $90 Million Renovation investment picks
WEST CHESTER, Ohio , July 25, 2014 /PRNewswire/ -- AK Steel (NYSE: AKS) said today that Sheri H.
Sign-up for Sheri H. Edison Named to AK Steel's Board of Directors investment picks
CLEVELAND , July 21, 2014 /PRNewswire/ -- The Sherwin-Williams Company (NYSE: SHW) has over 500 Research and Development employees in the greater Cleveland area.
Sign-up for Sherwin-Williams Cleveland HQ to Host R&D Career Expo July 23 and 24 - 4 to 7:00 p.m...Actively Seeking Chemists & Scientists investment picks
CLEVELAND , July 16, 2014 /PRNewswire/ -- The Board of Directors of The Sherwin-Williams Company (NYSE: SHW) today announced a regular quarterly dividend of $0.55 per common share, payable on September 5, 2014 , to shareholders of record on August 15 , 2014.
Sign-up for Sherwin-Williams Declares Dividend of $0.55 per Common Share investment picks
CLEVELAND , Sept.
Sign-up for Sherwin-Williams to Present at Credit Suisse Basic Materials Conference investment picks
SOUTHLAKE, Texas , Sept.
Sign-up for Sherwood Taipei increases revenue and bookings with Sabre Hospitality Solutions investment picks
http://media.marketwire.com/attachments/201407/266540_Suzo-Happlogonewtagline.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134585&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for SHIFT Interactive Secures an Agreement With Casino Powerhouse MGM Resorts International to Launch InteractivePro(TM) Tables investment picks
Made possible through company's industry-exclusive aluminum laser welding process VALLEY CITY, Ohio , Aug.
Sign-up for Shiloh Industries Develops Lightest Blanks In The Industry investment picks
http://media.marketwire.com/attachments/201405/75609_ShilohLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1140962&ProfileId=051205&sourceType=1 VALLEY CITY, OH --
Sign-up for Shiloh Industries Schedules Conference Call to Discuss 2014 Third Quarter Results investment picks
2014/8/28
HAMILTON, Bermuda, Aug.
Sign-up for Ship Finance International Limited (NYSE: SFL) - Earnings Release investment picks
2014/9/15
PHILADELPHIA , September 15, 2014 /PRNewswire/ -- Tell your doctor about any drug abuse, alcohol abuse or mental problems that you or your child has had, or about a family history of suicide, bipolar illness, or depression.
Sign-up for Shire Announces FDA Acceptance for Filing with Priority Review of Supplemental New Drug Application (sNDA) for Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) for Adults with Binge Eating Disorder investment picks
2014/7/18
DUBLIN , July 18, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
Sign-up for Shire Delivers Record Quarterly Revenues and Non GAAP Diluted Earnings per ADS up 42% investment picks
Strengthens Leadership Position in Treatments for Hunter syndrome and Commitment to MPS II Patient Community LEXINGTON, Massachusetts , July 23, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy (ERT) for the potential treatment of both the central nervous system (CNS) and somatic manifestations in patients with Hunter syndrome (MPS II). This collaboration strengthens Shire's rare disease pipeline of innovative therapies where there is high unmet need, and underscores the company's long standing commitment to the Hunter syndrome community.
Sign-up for Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen investment picks
Shire PLC (SHPG) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on September 01, 2014.
Sign-up for Shire Files 8K - Other Events investment picks
2014/7/8
DUBLIN , July 8, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
Sign-up for Shire plc - Statement re: AbbVie Announcement investment picks
2014/7/11
DUBLIN , July 11, 2014 /PRNewswire/ -- Not for release, publication or distribution (in whole or in part) in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.
Sign-up for Shire plc - Statement re: Media Speculation investment picks
2014/7/14
DUBLIN , July 14, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
Sign-up for Shire plc: Update re: AbbVie Proposal investment picks
2014/9/24
PHILADELPHIA , September 24, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), today announced that it has reached a final agreement with the U.S. Attorney's Offices for the Eastern District of Pennsylvania and Northern District of Illinois , all 50 states and the District of Columbia to resolve a previously disclosed civil investigation of its sales and marketing practices for a period ending in 2010 relating to ADDERALL XR ® , VYVANSE ® DAYTRANA ® , LIALDA ® and PENTASA ® .
Sign-up for Shire Reaches Final Agreement with U.S. Government investment picks
By Ian Walker LONDON --
Sign-up for Shire ready to recommend AbbVie's revised $53 billion offer investment picks
2014/7/17
LEXINGTON, Massachusetts , July 17, 2014 /PRNewswire/ -- In Children and Teenagers new psychotic symptoms such as: seeing things or hearing voices that are not real believing things that are not true being suspicious new manic symptoms Tell your doctor about any drug abuse, alcohol abuse or mental problems that you or your child has had, or about a family history of suicide, bipolar illness, or depression.
Sign-up for Shire Reports Top-Line Results From Two Head-to-Head Studies Comparing Vyvanse® (lisdexamfetamine dimesylate), CII, With Concerta® (methylphenidate HCl), CII, in Adolescents with ADHD investment picks
2014/7/18
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Shire plc (“Shire”) (NasdaqGS: SHPG) concerning the buyout by AbbVie.
Sign-up for SHIRE SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Buyout of Shire by AbbVie May be Unfair to Shareholders investment picks
2014/7/8
NEW YORK (MarketWatch) -- The U.S.-listed shares of the U.K.'s Shire rose 1.1% in active premarket trade after AbbVie said it increased its bid to buy the biopharmaceutical company by 11%. The new bid represents GBP22.44 a share in cash and 0.8568 AbbVie shares for each Shire share, which are now being valued at GBP51.15 each.
Sign-up for Shire shares rise in premarket trade after AbbVie ups buyout bid by 11% investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Shares of Shire PLC and AstraZeneca PLC were under pressure Tuesday, as tax-inversion moves by the U.S. weighed on the merger prospects for the pharmaceutical companies.
Sign-up for Shire, AstraZeneca fall in London after U.S. tax move investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Shell International Finance B.V. and Royal Dutch Shell plc to Shire, AstraZeneca fall in London after U.S. tax move
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices